Israel's pharmaceutical landscape is characterized by a high demand for integrative medicine. With a climate that fluctuates between extreme heat and temperate winters, there is a growing local preference for fruit flower tea to maintain hydration and reduce systemic inflammation.
Currently, the market relies heavily on imports. The challenge lies in the stability of active ingredients during long-distance transit from Asia to the Levant. Many local distributors struggle with maintaining the volatile aromatic oils essential for high-quality mum tea.
The regulatory environment in Israel is stringent regarding pesticide residues. This has created a significant gap in the market for certified organic chrysanthemum that meets both EU and local health ministry standards for pharmaceutical-grade herbal slices.